Watch for Zelnorm's Return for Irritable Bowel Syndrome With Constipation

October 2019

Zelnorm (tegaserod) will be back on the market to treat irritable bowel syndrome with constipation (IBS-C) in women.

It was first approved in 2002...then taken off the market in 2007 due to reports of MI, stroke, and unstable angina.

Since then, it's been available on a case-by-case basis from various manufacturers.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote